Abstract
Irritable bowel syndrome (IBS) is a chronic, recurring condition, prevalent in the general population. Current medication treatments usually leave patients undertreated. Nowadays, Chinese medicine (CM) is being considered as a promising treatment approach for IBS. However, due to methodological limitations, there is no strong evidence to support CM. Although IBS relapses are common, the relapse assessment has always been neglected in CM study designs. Meanwhile, in clinical practice and studies, it has been found that certain CM formulas can only benefit certain kinds of patients. Discovering what population and illness characteristics likely respond to outcomes may help improve the effectiveness of CM. The aims of this study are to evaluate the efficacy and safety of Tiao-Chang Ke-Min (TCKM) granules for IBS, especially in reducing IBS symptoms' relapse, by a high-quality randomized controlled trial and then to optimize the indication of the TCKM granules. This is a parallel-group, randomized, double-blind, placebo-controlled trial embedded with outcome predictive factors. Eligible patients with diarrhea-predominant IBS will be randomized into either a TCKM granule group or a placebo group. Patients from both groups will recei...Continue Reading
References
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Apr 1, 1997·Alimentary Pharmacology & Therapeutics·C Y FrancisP J Whorwell
Mar 25, 1998·Digestive Diseases and Sciences·D L PatrickK L Puder
May 29, 1998·The Journal of International Medical Research·A W MangelD McSorley
Nov 20, 1998·JAMA : the Journal of the American Medical Association·A BensoussanM Ngu
Apr 15, 2004·Alimentary Pharmacology & Therapeutics·H B El-SeragP Schoenfeld
May 9, 2006·Gastroenterology·George F LongstrethRobin C Spiller
Jul 26, 2006·The American Journal of Gastroenterology·Wai K LeungJoseph J Y Sung
Jan 18, 2008·World Journal of Gastroenterology : WJG·Jun ShiHai-Xia Li
May 2, 2009·Chinese Journal of Integrative Medicine·Zhi-peng Tang
Jun 23, 2009·Journal of the Chinese Medical Association : JCMA·Full-Young Chang, Ching-Liang Lu
Feb 23, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jeffrey M LacknerLeonard A Katz
Mar 24, 2010·Journal of Psychosomatic Research·Silje Endresen RemeTrudie Chalder
May 13, 2010·Current Pharmaceutical Design·Yasunori SatoTeruhiko Yoshida
May 26, 2010·Alimentary Pharmacology & Therapeutics·Y ZhaoJ He
Apr 2, 2011·Journal of Gastroenterology and Hepatology·Jinsong Liu, Xiaohua Hou
Oct 8, 2011·Trials·Seok-Jae KoJae-Woo Park
Nov 17, 2012·The International Journal of Clinical and Experimental Hypnosis·Charles D GersonMary-Joan Gerson
Nov 20, 2013·BMC Gastroenterology·Brjánn LjótssonErik Hedman
Nov 22, 2013·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Megan C ChangBruce D Naliboff
Feb 28, 2014·World Journal of Gastroenterology : WJG·Oliver Grundmann, Saunjoo L Yoon
Mar 15, 2014·World Journal of Gastroenterology : WJG·Full-Young Chang
Sep 28, 2014·Drugs·Jose L BarbozaBaharak Moshiree
Jan 13, 2015·The American Journal of Chinese Medicine·Hai-Tao XiaoZhao-Xiang Bian
Feb 27, 2015·BMJ : British Medical Journal·Cheryl HookwayDamien Longson
May 5, 2016·Gastroenterology·Douglas A Drossman